Actavis Acquiring Warner Chilcott For $8.5 Billion

Actavis Inc (NYSE:ACT) today announced its definitive agreement to acquire Warner Chilcott plc (NASDAQ:WCRX) in an all stock transaction valued at approximately $8.5 billion. Actavis, Warner Chilcott Deal: The generic drug maker Actavis Inc (NYSE:ACT) is to acquire the specialty pharmaceutical company Warner Chilcott. The deal  means that Warner Chilcott shareholders to receive 0.16  shares of Actavis for each Warner Chilcott plc (NASDAQ:WCRX) shares held.  This would value Actavis shares at $20.08, a premium of 4.5 percent over Friday’s close. Actavis shareholders would receive one share of New Actavis for each Actavis share owned by them. Shares of Actavis Inc (NYSE:ACT) shot up by 1.8…